Solgate GmbH
Solgate GmbH is an innovative drug discovery company focused on developing novel medicines that target solute carriers (SLCs), a superfamily of membrane transport proteins implicated in a wide range of human diseases across diverse therapeutic areas.
Solgate's goal is to develop small molecule-based programs with the potential to transform the treatment landscape in immunology, central nervous system (CNS) disorders, and metabolic diseases.
We believe that SLCs represent a groundbreaking opportunity in drug discovery, offering the potential to revolutionize existing treatment paradigms and significantly improve the lives of patients worldwide.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}